148 related articles for article (PubMed ID: 1501780)
1. Increase of plasma neuropeptide Y-like immunoreactivity following chronic hypoxia in the rat.
Cheng JT; Chen CF; Shum AY; Wang JY; Chen HI
Neurosci Lett; 1992 Jun; 140(2):211-4. PubMed ID: 1501780
[TBL] [Abstract][Full Text] [Related]
2. Effects of vinblastine on neuropeptide Y levels in the sympathoadrenal system, bone marrow and thrombocytes of the rat.
Hemsén A; Pernow J; Millberg BI; Lundberg JM
Agents Actions; 1991 Nov; 34(3-4):429-38. PubMed ID: 1810152
[TBL] [Abstract][Full Text] [Related]
3. Reserpine-induced depletion of neuropeptide Y from cardiovascular nerves and adrenal gland due to enhanced release.
Lundberg JM; Al-Saffar A; Saria A; Theodorsson-Norheim E
Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):163-8. PubMed ID: 3010140
[TBL] [Abstract][Full Text] [Related]
4. Age-related bidirectional changes in neuropeptide Y peptides in rat adrenal glands, brain, and blood.
Higuchi H; Yang HY; Costa E
J Neurochem; 1988 Jun; 50(6):1879-86. PubMed ID: 3373217
[TBL] [Abstract][Full Text] [Related]
5. Stress-induced changes of circulating neuropeptide Y in the rat: comparison with catecholamines.
Castagné V; Corder R; Gaillard R; Mormède P
Regul Pept; 1987 Oct; 19(1-2):55-63. PubMed ID: 3317527
[TBL] [Abstract][Full Text] [Related]
6. Alteration in central and peripheral substance P- and neuropeptide Y-like immunoreactivity after chronic hypoxia in the rat.
Poncet L; Denoroy L; Dalmaz Y; Pequignot JM; Jouvet M
Brain Res; 1996 Sep; 733(1):64-72. PubMed ID: 8891249
[TBL] [Abstract][Full Text] [Related]
7. Alterations in circulating levels and cardiovascular tissue content of neuropeptide Y-like immunoreactivity during the development of deoxycorticosterone acetate-salt hypertension in the rat.
Moreau P; de Champlain J; Yamaguchi N
J Hypertens; 1992 Aug; 10(8):773-80. PubMed ID: 1325509
[TBL] [Abstract][Full Text] [Related]
8. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man.
Pernow J; Lundberg JM; Kaijser L; Hjemdahl P; Theodorsson-Norheim E; Martinsson A; Pernow B
Clin Physiol; 1986 Dec; 6(6):561-78. PubMed ID: 3466738
[TBL] [Abstract][Full Text] [Related]
9. Co-release of neuropeptide Y and catecholamines upon adrenal activation in the cat.
Lundberg JM; Fried G; Pernow J; Theodorsson-Norheim E
Acta Physiol Scand; 1986 Feb; 126(2):231-8. PubMed ID: 3754683
[TBL] [Abstract][Full Text] [Related]
10. Circulating neuropeptide Y (NPY) and catecholamines in rat under resting and stress conditions. Arguments for extra-adrenal origin of NPY, adrenal and extra-adrenal sources of catecholamines.
Bernet F; Dedieu JF; Laborie C; Montel V; Dupouy JP
Neurosci Lett; 1998 Jun; 250(1):45-8. PubMed ID: 9696062
[TBL] [Abstract][Full Text] [Related]
11. Increases in plasma neuropeptide Y concentrations during sympathetic activation in man.
Morris MJ; Russell AE; Kapoor V; Cain MD; Elliott JM; West MJ; Wing LM; Chalmers JP
J Auton Nerv Syst; 1986 Oct; 17(2):143-9. PubMed ID: 3782722
[TBL] [Abstract][Full Text] [Related]
12. Increased plasma levels of neuropeptide Y-like immunoreactivity and catecholamines in severe hypertension remain after treatment to normotension in man.
Edvinsson L; Ekman R; Thulin T
Regul Pept; 1991 Feb; 32(3):279-87. PubMed ID: 1866472
[TBL] [Abstract][Full Text] [Related]
13. Elevations of neuropeptide Y-like immunoreactivity and catecholamines in plasma on increased intracranial pressure in the pig.
Rudehill A; Lundberg JM; Sollevi A; Hjemdahl P
Acta Anaesthesiol Scand; 1987 Feb; 31(2):132-8. PubMed ID: 3564869
[TBL] [Abstract][Full Text] [Related]
14. Splanchnic nerve transection abolishes the age-dependent increase of neuropeptide Y-like immunoreactivity in rat adrenal gland.
Higuchi H; Yang HY
J Neurochem; 1986 May; 46(5):1658-60. PubMed ID: 3754274
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of propofol on sympathetic neurotransmission results in changes of plasma neuropeptide Y in rats.
Chang CL; Tsai YC; Niu CS; Hung SF; Cheng JT
J Auton Pharmacol; 1996 Feb; 16(1):29-33. PubMed ID: 8736428
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y-like immunoreactivity and hypertension.
Erlinge D; Ekman R; Thulin T; Edvinsson L
J Hypertens; 1992 Oct; 10(10):1221-5. PubMed ID: 1335004
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y in the adrenal gland: characterization, distribution and drug effects.
de Quidt ME; Emson PC
Neuroscience; 1986 Nov; 19(3):1011-22. PubMed ID: 3540720
[TBL] [Abstract][Full Text] [Related]
18. Alpha-adrenoceptor influence on plasma levels of neuropeptide Y-like immunoreactivity and catecholamines during rest and sympathoadrenal activation in humans.
Pernow J; Lundberg JM; Kaijser L
J Cardiovasc Pharmacol; 1988; 12(5):593-9. PubMed ID: 2468060
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of neuropeptide Y immunoreactivity in patients with pheochromocytoma: influence on the diagnostic power of measuring plasma NPY using antisera with different specificities.
Tabarin A; Cassiède P; Minot AP; Cuber JC; Roger P; Ducassou D
Acta Endocrinol (Copenh); 1993 Mar; 128(3):243-50. PubMed ID: 8480474
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms underlying changes in the contents of neuropeptide Y in cardiovascular nerves and adrenal gland induced by sympatholytic drugs.
Lundberg JM; Saria A; Franco-Cereceda A; Theodorsson-Norheim E
Acta Physiol Scand; 1985 Aug; 124(4):603-11. PubMed ID: 3840321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
